This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through September 7, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
smart-health: Archive
UnitedHealth vs. Humana: Which Healthcare Giant Has the Edge?
by Rajshree Sipani
UNH's diversified healthcare platform, improving Medicare Advantage profitability and lower valuation give it an edge over HUM.
UNHPositive Net Change HUMPositive Net Change
artificial-intelligence automation dividend dividend-yield earnings-surprise healthcare hmo hospitals insurance medical smart-health
Teladoc Strengthens Solo Platform With New AI-Powered Care Tools
by Zacks Equity Research
TDOC expands Solo with AI tools that streamline virtual assessments and clinical documentation, targeting simpler workflows for hospitals.
TDOCPositive Net Change PAHCPositive Net Change WGSNegative Net Change CONPositive Net Change
artificial-intelligence medical smart-health
Encompass Health Expands Rehab Footprint With New Maine Hospital
by Zacks Equity Research
EHC opens a 50-bed Maine rehab hospital, expanding its footprint as strong discharge growth and planned openings support capacity expansion.
EHCPositive Net Change PAHCPositive Net Change WGSNegative Net Change CONPositive Net Change
medical smart-health
Aflac Strengthens Benefits Tech With bswift's AI-Powered Tools
by Zacks Equity Research
AFL is advancing workplace benefits with bswift's AI-powered tools, simplifying plan configuration and potentially improving access to its voluntary products.
AFLNegative Net Change HMNNegative Net Change HRTGNegative Net Change AIINegative Net Change
artificial-intelligence automation fin-tech finance insurance smart-health
Vicor (VICR) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
VICRPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Centene Narrows Medicare Advantage Footprint as Costs Remain Elevated
by Rajshree Sipani
CNC is narrowing its 2027 Medicare Advantage footprint as elevated costs pressure plan economics, with a sharper focus on dual eligibles.
CNCPositive Net Change UNHPositive Net Change HUMPositive Net Change
insurance medical smart-health
Should You Buy PTC Inc. (PTC) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
PTCPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
UNH Exits Select Medicare Advantage Plans for 2027 Amid Cost Pressure
by Rajshree Sipani
UnitedHealth is exiting select Medicare Advantage plans for 2027 as rising medical costs pressure profitability, reshaping its membership mix.
UNHPositive Net Change HUMPositive Net Change CNCPositive Net Change
artificial-intelligence insurance medical smart-health
LuxExperience B.V. - Sponsored ADR (LUXE)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
LUXENegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Solana Company (HSDT) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
HSDTPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines